Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New application of DCIK cell culture supernatant preparation

A technology of DCIK and cell culture, applied in the application field of DCIK cell culture supernatant preparation in the preparation of intra-antibody tumor drugs, can solve the problem of unsatisfactory clinical application effect of a single cytokine, and achieve good anti-tumor activity effect

Inactive Publication Date: 2010-03-03
SHANGHAI UNIV
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is reasonable to speculate that the mixed cytokine network in the cell culture supernatant may also have tumor-specific killing activity; moreover, due to the pleiotropy, antagonism, bidirectionality of cytokine action, and the interaction of signaling pathways mediated by it However, the clinical effect of a single cytokine is often unsatisfactory, while a combination of cytokines naturally produced by immune effector cells may achieve significant results

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of DCIK cell culture supernatant preparation
  • New application of DCIK cell culture supernatant preparation
  • New application of DCIK cell culture supernatant preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0013] For the preparation method of the DCIK cell culture supernatant preparation, please refer to the Chinese patent application number 200810038429.4 titled "DCIK cell culture supernatant and its application".

[0014] The materials used are as follows and the materials and methods are as follows:

[0015] 1. Experimental materials

[0016] 1. Biologics

[0017] RPMI 1640 medium: purchased from Hyclone Company;

[0018] Newborn fetal bovine serum: purchased from Hangzhou Sijiqing Company;

[0019] Complete medium: RPMI 1640 medium, adding 10% newborn fetal bovine serum;

[0020] 5-FU specification; 250mg / bottle, produced by Shanghai Hualian Pharmaceutical Co., Ltd.

[0021] 2. Reagent formula

[0022] 1×PBS (PH7.4): Dissolve 8.0gNaCl, 0.2gKCl, 1.44gNa2HPO4 and 0.24gKH2PO4 in 800ml of high-purity water; adjust the pH of the solution to 7.4 with HCl, add water to make up to 1 liter. Autoclave at 121°C for 20 minutes; store at room temperature.

[0023] Trypsin: 0.25% T...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the application of a DCIK cell culture supernatant preparation in the preparation of in-vivo anti-tumor medicines. The invention indicates that the DCIK preparation has 58.10percent of the tumor inhibition rate and favorable anti-tumor activity in vivo; and the tumor inhibition rate reaches up to 88.20 percent when the DCIK preparation and 5-fu are combined, which promptsthat the DCIK preparation and the 5-fu have synergistic effect in vivo. A preliminary result proves that the DCIK preparation has favorable in-vivo application effectiveness to a human gastric cancerSGC-7901 naked mouse transplantation tumor model, and the potential development value as a medicine for preventing and controlling human gastric cancer is displayed whatever the preparation is used singly or combined with chemotherapeutics. The invention indicates that the DCIK preparation really has final anti-tumor biological effect under the complex environments in vivo and fully shows the application development values when the DCIK preparation is used singly or combined with the chemotherapeutics.

Description

technical field [0001] The invention relates to a new application of a DCIK cell culture supernatant preparation, in particular to an application of a DCIK cell culture supernatant preparation in the preparation of an intrabody tumor drug. Background technique [0002] In recent years, biological therapy has become a rapidly developing research field in tumor treatment technology, among which cytokine therapy has shown a good development prospect. The anti-tumor mechanism of cytokines mainly involves: controlling the growth of cancer cells and promoting differentiation; regulating the host's immune response; directly killing tumor cells; inducing tumor cell apoptosis and interfering with the growth cycle of tumor cells; destroying tumor blood vessels and nutrient supply ; Stimulate hematopoietic function, promote bone marrow recovery, etc. [0003] DCIK cells are effector cell populations obtained by co-culture of dendritic cells (DC) and cytokine-induced killer cells (CIK)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/12A61P35/00A61K35/15
Inventor 陈宇光李艳霞石英俊吴涤梵张尚权姚刚李逸平
Owner SHANGHAI UNIV
Features
  • Generate Ideas
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com